4.6 Article

Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in Patients With Hutchinson-Gilford Progeria Syndrome

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome

Leslie B. Gordon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Cell & Tissue Engineering

Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs

Guang-Hui Liu et al.

CELL STEM CELL (2011)

News Item Medicine, Research & Experimental

Human pluripotent stem cells: opening key for pathological modeling

Yves Maury et al.

M S-MEDECINE SCIENCES (2011)

Article Multidisciplinary Sciences

Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome

Guang-Hui Liu et al.

NATURE (2011)

Article Medicine, Research & Experimental

Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade

Jianhui Ma et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Biochemistry & Molecular Biology

Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging

Sofia Rodriguez et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2009)

Article Cell Biology

Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing

Paola Scaffidi et al.

NATURE CELL BIOLOGY (2008)

Review Cell Biology

HGPS and related premature aging disorders:: From genomic identification to the first therapeutic approaches

Sandrine Pereira et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2008)

Article Medicine, General & Internal

Phenotype and course of Hutchinson-Gilford progeria syndrome

Melissa A. Merideth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Multidisciplinary Sciences

A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model

Brian C. Capell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Kazutoshi Takahashi et al.

Review Genetics & Heredity

Hutchinson-Gifford Progeria syndrome: Review of the phenotype

Raoul C. M. Hennekam

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)

Review Biochemistry & Molecular Biology

Molecular bases of progeroid syndromes

Claire L. Navarro et al.

HUMAN MOLECULAR GENETICS (2006)

Article Medicine, Research & Experimental

A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation

Shao H. Yang et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Multidisciplinary Sciences

Lamin A-dependent nuclear defects in human aging

P Scaffidi et al.

SCIENCE (2006)

Article Multidisciplinary Sciences

Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome

BC Capell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Lamin A truncation in Hutchinson-Gilford progeria

A De Sandre-Giovannoli et al.

SCIENCE (2003)

Article Biochemistry & Molecular Biology

Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy

B Ravikumar et al.

HUMAN MOLECULAR GENETICS (2002)